RL vs SLNO · P/E 24, rev $8.11B vs P/E 27, $2.76B cap
Ralph Lauren Corp Class A (RL) versus Soleno Therapeutics Inc (SLNO) — a side-by-side from cached financials, not a winner call.
Ralph Lauren Corp Class A (RL) is a apparel manufacturing company listed on US.
Soleno Therapeutics Inc (SLNO) is a biotechnology company listed on NASDAQ.
Latest reported RL revenue for 2026-03-28 was $8.11B. Net income was $941.1M. Revenue was up 14.6% from 2025-03-29 to 2026-03-28. RL currently screens at market cap $16.95B and trailing P/E 24.1.
SLNO does not have a complete income-statement cache yet.
RL currently screens at market cap $16.95B and trailing P/E 24.1. SLNO currently screens at market cap $2.76B and trailing P/E 27.5.
Not investment advice. Open the RL and SLNO stock pages for the full models.
Not investment advice.